Smoking increases breast toxicity despite adjuvant hypofractionated IMRT in early breast cancer
Loading...
Identifiers
Publication date
Advisors
Editors
Journal Title
Journal ISSN
Volume Title
Publisher
SDG
Metrics
Abstract
The aim of this study is to evaluate the impact of smoking on acute and chronic toxicity in early breast cancer patients treated with hypofractionated intensity-modulated radiation therapy (IMRT) and a brachytherapy boost following breast-conserving surgery. Acute toxicity was assessed at treatment end and chronic toxicity at least one-year post-treatment, using Common Terminology Criteria for Adverse Events v4.0. Statistical analyses included chi-square tests and relative risk (RR) calculations.
Description
UNESCO Subjects
Keywords
Bibliographic reference
Díaz-Gavela, A. A., Del Cerro, E., Sanchez-Garcia, S., Andreu-Vázquez, C., Thuissard-Vasallo, I. J., Sanz-Rosa, D., Pena-Huertas, M., Ruiz-Morales, C., Guerrero-Gomez, L. L., Duque-Santana, V., Hernandez-Cortés, G., Gonzalez-Cortijo, L., & Counago, F. (2025). Smoking increases breast toxicity despite adjuvant hypofractionated IMRT in early breast cancer. Radiation Oncology, 20(1), 45. https://doi.org/10.1186/s13014-025-02614-x
Editor's version
https://doi.org/10.1186/s13014-025-02614-xType of document
Collections
La licencia de este ítem se describe como Attribution-NonCommercial-NoDerivatives 4.0 International